FIELD: chemistry.
SUBSTANCE: in general formula (I) p equals 1 or 2; R1 is methyl, ethyl, propyl, isobutyl, 2-fluoroethyl or cyclobutyl; m equals 0; each R2 is absent; n equals 0; each R3 is absent; R4 is a hydrogen atom; R5 is a hydrogen atom; R6 is -C(O)O-R6a; R6a is a C1-C6alkyl group which can have 1-3 substitutes selected from a group of substitutes α, where the group of substitutes α is a group consisting of a halogen atom, a hydroxyl group, a C1-C6alkoxy group, a C3-C7cycloalkyl group, an amino group, a mono- or di(C1-C6alkyl)amino group, a phenyl group, and a furyl group; and R7 is a hydrogen atom.
EFFECT: compounds have the property of reducing the blood glucose level and can be used to treat and/or prevent type 1 sugar diabetes, type 2 sugar diabetes or diabetes-associated diseases caused by low glucose tolerance, as well as to prevent obesity caused by low glucose tolerance.
11 cl, 2 tbl, 119 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED GUANIDINE DERIVATIVES | 2016 |
|
RU2733951C2 |
FURIN INHIBITORS | 2019 |
|
RU2799824C2 |
BROMDOMAIN INHIBITORS | 2012 |
|
RU2671571C1 |
BROMDOMAIN INHIBITORS | 2012 |
|
RU2647592C2 |
CONDENSED 4-OXOPYRIMIDINE DERIVATIVE | 2005 |
|
RU2358969C2 |
SUBSTITUTED PYRIDINE COMPOUND | 2011 |
|
RU2572606C2 |
NEW β-LACTAMASE INHIBITOR AND A METHOD OF ITS PRODUCTION | 2019 |
|
RU2800050C2 |
NOVEL BETA-LACTAMASE INHIBITOR AND METHOD FOR PRODUCTION THEREOF | 2013 |
|
RU2693898C2 |
NEW AMINOARYL DERIVATIVE SUITABLE AS A DIACYLGLYCEROLACYL TRANSFERASE 2 INHIBITOR AND ITS APPLICATION | 2020 |
|
RU2799819C1 |
INHIBITOR COMPOUNDS | 2013 |
|
RU2673079C2 |
Authors
Dates
2012-10-20—Published
2008-10-15—Filed